세계의 심방세동 시장 - 산업규모, 점유율, 동향, 기회, 예측, 치료유형별(약리학적 치료), 비약리학적 치료, 최종용도별, 지역별, 경쟁별(2020-2030년)

The Global Atrial Fibrillation Market was valued at USD 22.54 Billion in 2024 and is projected to reach USD 34.18 Billion by 2030, growing at a CAGR of 7.19% during the forecast period. Atrial fibrillation, a prevalent cardiac arrhythmia marked by irregular and often rapid heartbeats, significantly increases the risk of stroke, heart failure, and other cardiovascular complications. Its growing incidence globally is attributed to factors such as the aging population, increasing obesity rates, and lifestyle-induced health issues. This condition poses a considerable clinical and financial burden on healthcare systems. The COVID-19 pandemic, while reducing cardiac surgeries, emphasized the importance of digital healthcare approaches like telemedicine and remote monitoring-trends that are expected to persist and support market growth. As a result, the demand for effective atrial fibrillation management continues to rise, driving advancements in treatment and diagnosis.

Key Market Drivers

Increasing Aging Population is Driving the Global Atrial Fibrillation Market

The growing global aging population is a major factor fueling the expansion of the atrial fibrillation market. Older individuals are more susceptible to this condition due to age-related health risks such as hypertension, obesity, and diabetes. As the proportion of elderly people rises, so does the prevalence of atrial fibrillation. According to the American Heart Association, the likelihood of developing atrial fibrillation doubles with every decade after age 50. Additionally, the World Health Organization reports that by 2030, one in six people globally will be over 60, with the number expected to reach 2.1 billion by 2050. This demographic trend is significantly influencing the demand for atrial fibrillation therapies and solutions.

Key Market Challenges

Lack of awareness

A major hurdle in combating atrial fibrillation globally is the widespread lack of awareness. Despite being common, the condition often goes undiagnosed or is insufficiently treated. This is largely due to limited public understanding of its symptoms and potential severity, resulting in delayed diagnoses and inadequate interventions. The insufficient awareness among both patients and healthcare providers continues to impede efforts to effectively manage and reduce the burden of atrial fibrillation worldwide.

Key Market Trends

Technological Advancements

Technological innovations are transforming the diagnosis and management of atrial fibrillation, leading to improved patient outcomes and more efficient healthcare delivery. As the most common form of cardiac arrhythmia, atrial fibrillation can result in serious complications, making early and accurate detection critical. Advanced tools and procedures, including minimally invasive surgical techniques and remote monitoring solutions, are gaining prominence. These developments cater to growing demand for safer, more precise treatment methods and are playing a pivotal role in expanding the global atrial fibrillation market.

Key Market Players

• Parexel International Corporation
• AtriCure Inc.
• Boehringer Ingelheim GmbH
• Boston Scientific Corporation
• Bristol- Myers Squibb Corporation
• Cardio Focus Inc.
• Sanofi Aventis
• Biosense Webster Inc.
• Endoscopic Technologies Inc.
• Abbott Laboratories
• Johnsons & Johnson Services, Inc.

Report Scope:

In this report, the Global Atrial Fibrillation Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Atrial Fibrillation Market, By Treatment Type:

• Pharmacological Treatment
• Non-Pharmacological Treatment

Atrial Fibrillation Market, By End Use:

• Hospital
• Specialty Clinics
• Others

Atrial Fibrillation Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Atrial Fibrillation Market.

Available Customizations:

Global Atrial Fibrillation market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

4. Voice of Customer

5. Global Atrial Fibrillation Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Treatment Type (Pharmacological Treatment (Anti-arrhythmic Drugs), Non-Pharmacological Treatment(Catheter Ablation, Maze Surgery, Electric Cardioversion)
  • 5.2.2. By End-use (Hospital, Specialty Clinics, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. North America Atrial Fibrillation Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Treatment Type
  • 6.2.2. By End-Use
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Atrial Fibrillation Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Treatment Type
      • 6.3.1.2.2. By End-Use
  • 6.3.2. Canada Atrial Fibrillation Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Treatment Type
      • 6.3.2.2.2. By End-Use
  • 6.3.3. Mexico Atrial Fibrillation Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Treatment Type
      • 6.3.3.2.2. By End-Use

7. Europe Atrial Fibrillation Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Treatment Type
  • 7.2.2. By End-Use
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Atrial Fibrillation Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Treatment Type
      • 7.3.1.2.2. By End-Use
  • 7.3.2. United Kingdom Atrial Fibrillation Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Treatment Type
      • 7.3.2.2.2. By End-Use
  • 7.3.3. Italy Atrial Fibrillation Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Treatment Type
      • 7.3.3.2.2. By End-Use
  • 7.3.4. France Atrial Fibrillation Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Treatment Type
      • 7.3.4.2.2. By End-Use
  • 7.3.5. Spain Atrial Fibrillation Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Treatment Type
      • 7.3.5.2.2. By End-Use

8. Asia-Pacific Atrial Fibrillation Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Treatment Type
  • 8.2.2. By End-Use
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Atrial Fibrillation Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Treatment Type
      • 8.3.1.2.2. By End-Use
  • 8.3.2. India Atrial Fibrillation Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Treatment Type
      • 8.3.2.2.2. By End-Use
  • 8.3.3. Japan Atrial Fibrillation Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Treatment Type
      • 8.3.3.2.2. By End-Use
  • 8.3.4. South Korea Atrial Fibrillation Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Treatment Type
      • 8.3.4.2.2. By End-Use
  • 8.3.5. Australia Atrial Fibrillation Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Treatment Type
      • 8.3.5.2.2. By End-Use

9. South America Atrial Fibrillation Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Treatment Type
  • 9.2.2. By End-Use
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Atrial Fibrillation Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Treatment Type
      • 9.3.1.2.2. By End-Use
  • 9.3.2. Argentina Atrial Fibrillation Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Treatment Type
      • 9.3.2.2.2. By End-Use
  • 9.3.3. Colombia Atrial Fibrillation Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Treatment Type
      • 9.3.3.2.2. By End-Use

10. Middle East and Africa Atrial Fibrillation Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Treatment Type
  • 10.2.2. By End-Use
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Atrial Fibrillation Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Treatment Type
      • 10.3.1.2.2. By End-Use
  • 10.3.2. Saudi Arabia Atrial Fibrillation Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Treatment Type
      • 10.3.2.2.2. By End-Use
  • 10.3.3. UAE Atrial Fibrillation Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Treatment Type
      • 10.3.3.2.2. By End-Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition
• 12.2. Product Development
• 12.3. Recent Developments

13. Global Atrial Fibrillation Market: SWOT Analysis

14. Competitive Landscape

• 14.1. Parexel International Corporation
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. AtriCure Inc.
• 14.3. Boehringer Ingelheim GmbH
• 14.4. Boston Scientific Corporation
• 14.5. Bristol- Myers Squibb Corporation
• 14.6. Cardio Focus Inc.
• 14.7. Sanofi Aventis
• 14.8. Biosense Webster Inc.
• 14.9. Endoscopic Technologies Inc.
• 14.10. Abbott Laboratories
• 14.11. Johnsons & Johnson Services, Inc.

15. Strategic Recommendations

16. About Us & Disclaimer